医学
复苏
新生儿复苏
新生儿学
临床试验
儿科
早产
重症监护医学
急诊医学
麻醉
怀孕
妊娠期
内科学
遗传学
生物
作者
James X. Sotiropoulos,Vishal Kapadia,Máximo Vento,Yacov Rabi,Ola Didrik Saugstad,R. Kishore Kumar,Georg M. Schmölzer,Huyan Zhang,Yuan Yuan,Gina Lim,Satoshi Kusuda,Takeshi Arimitsu,Tinh T. Nguyen,Ratchada Kitsommart,Kee Thai Yeo,Ju Lee Oei
摘要
The aim of this study was to determine clinician opinion regarding oxygen management in moderate-late preterm resuscitation.An anonymous online questionnaire was distributed through email/social messaging platforms to neonatologists in 21 countries (October 2020-March 2021) via REDCap.Of the 695 respondents, 69% had access to oxygen blenders and 90% had pulse oximeters. Respondents from high-income countries were more likely to have oxygen blenders than those from middle-income countries (72% vs. 66%). Most initiated respiratory support with FiO2 0.21 (43%) or 0.3 (36%) but only 45% titrated FiO2 to target SpO2 . Most (89%) considered heart rate as a more important indicator of response than SpO2 . Almost all (96%) supported the need for well-designed trials to examine oxygenation in moderate-late preterm resuscitation.Most clinicians resuscitated moderate-late preterm infants with lower initial FiO2 but some cannot/will not target SpO2 or titrate FiO2 . Most consider heart rate as a more important indicator of infant response than SpO2 .Large and robust clinical trials examining oxygen use for moderate-late preterm resuscitation, including long-term neurodevelopmental outcomes, are supported amongst clinicians.
科研通智能强力驱动
Strongly Powered by AbleSci AI